• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因出血而再次手术探查是心脏手术后不良预后的一个风险因素。

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.

作者信息

Moulton M J, Creswell L L, Mackey M E, Cox J L, Rosenbloom M

机构信息

Department of Surgery, Division of Cardiothoracic Surgery, Washington University, St. Louis, MO 63110, USA.

出版信息

J Thorac Cardiovasc Surg. 1996 May;111(5):1037-46. doi: 10.1016/s0022-5223(96)70380-x.

DOI:10.1016/s0022-5223(96)70380-x
PMID:8622301
Abstract

OBJECTIVE

Although previous studies have included early reexploration for bleeding as a risk factor in analyzing adverse outcomes after cardiac operations, reexploration for bleeding has not been systematically examined as a multivariate risk factor for increased morbidity and mortality after cardiac surgery. Furthermore, multivariate predictors of the need for reexploration have not been identified. Accordingly, we performed a retrospective analysis of 6100 patients requiring cardiopulmonary bypass from January 1, 1986, to December 31, 1993.

METHODS

Eighty-five patients who had ventricular assist devices were excluded from further analysis because of the prevalence of bleeding and the significant morbidity and mortality associated with placement of a ventricular assist device, unrelated to reexploration. In the remaining 6015 patients, potential adverse outcomes analyzed included operative mortality, mediastinitis, stroke, renal failure, adult respiratory distress syndrome, prolonged mechanical ventilation, sepsis, atrial arrhythmias, and ventricular arrhythmias. To control for the confounding effects of other risk factors, we performed a multivariate logistic regression analysis. Potential covariates considered in the logistic model included age, sex, race, history of reoperation, urgency of the operation, congestive heart failure, prior myocardial infarction, renal failure, diabetes, hypertension, chronic obstructive pulmonary disease or stroke, and the bypass and crossclamp time.

RESULTS

The overall incidence of reexploration was 4.2% (253/6015). Four independent risk factors--increased patient age (p < 0.001), preoperative renal insufficiency (p = 0.02), operation other than coronary bypass (p < 0.001), and prolonged bypass time (p = 0.0.3)--were identified as predictors of the need for reexploration. The preoperative use of aspirin, heparin, or thrombolytic agents and the bleeding time were not identified as predictors. Reexploration for bleeding was identified as a strong independent risk factor for operative mortality (p = 0.005), renal failure (p < 0.0001), prolonged mechanical ventilation (p < 0.0001), adult respiratory distress syndrome (p = 0.03), sepsis (p < 0.0001), and atrial arrhythmias (p = 0.006).

CONCLUSION

These data indicate that meticulous attention to surgical hemostasis and possibly application of recently developed modalities designed to facilitate perioperative correction of coagulopathy could improve outcomes after cardiac operations.

摘要

目的

尽管以往研究在分析心脏手术后不良结局时已将因出血进行早期再次手术探查作为一个危险因素,但因出血进行再次手术探查作为心脏手术后发病率和死亡率增加的多变量危险因素尚未得到系统研究。此外,尚未确定再次手术探查必要性的多变量预测因素。因此,我们对1986年1月1日至1993年12月31日期间需要进行体外循环的6100例患者进行了回顾性分析。

方法

85例使用心室辅助装置的患者被排除在进一步分析之外,因为这些患者出血发生率高,且与再次手术探查无关的心室辅助装置置入相关的显著发病率和死亡率。在其余6015例患者中,分析的潜在不良结局包括手术死亡率、纵隔炎、中风、肾衰竭、成人呼吸窘迫综合征、机械通气时间延长、脓毒症、房性心律失常和室性心律失常。为控制其他危险因素的混杂效应,我们进行了多变量逻辑回归分析。逻辑模型中考虑的潜在协变量包括年龄、性别、种族、再次手术史、手术紧急程度、充血性心力衰竭、既往心肌梗死、肾衰竭、糖尿病、高血压、慢性阻塞性肺疾病或中风以及体外循环和主动脉阻断时间。

结果

再次手术探查的总体发生率为4.2%(253/6015)。四个独立危险因素——患者年龄增加(p<0.001)、术前肾功能不全(p = 0.02)、非冠状动脉搭桥手术(p<0.001)和体外循环时间延长(p = 0.03)——被确定为再次手术探查必要性的预测因素。术前使用阿司匹林、肝素或溶栓药物以及出血时间未被确定为预测因素。因出血进行再次手术探查被确定为手术死亡率(p = 0.005)、肾衰竭(p<0.0001)、机械通气时间延长(p<0.0001)、成人呼吸窘迫综合征(p = 0.03)、脓毒症(p<0.0001)和房性心律失常(p = 0.006)的强有力独立危险因素。

结论

这些数据表明,认真关注手术止血以及可能应用最近开发的旨在促进围手术期凝血功能障碍纠正的方法,可能会改善心脏手术后的结局。

相似文献

1
Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations.因出血而再次手术探查是心脏手术后不良预后的一个风险因素。
J Thorac Cardiovasc Surg. 1996 May;111(5):1037-46. doi: 10.1016/s0022-5223(96)70380-x.
2
Obesity is not a risk factor for significant adverse outcomes after cardiac surgery.肥胖并非心脏手术后发生严重不良后果的风险因素。
Circulation. 1996 Nov 1;94(9 Suppl):II87-92.
3
Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay.冠状动脉搭桥术后出血的再次探查:危险因素、结果及时间延迟的影响
Ann Thorac Surg. 2004 Aug;78(2):527-34; discussion 534. doi: 10.1016/j.athoracsur.2004.02.088.
4
Reexploration for Bleeding and Its Association With Mortality After Cardiac Surgery.心脏手术后出血的再次探查及其与死亡率的关联
Ann Thorac Surg. 2016 Jul;102(1):109-17. doi: 10.1016/j.athoracsur.2016.01.006. Epub 2016 Mar 26.
5
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group.冠状动脉旁路移植术后出血再次探查:发生率及危险因素。新英格兰北部心血管疾病研究组
Arch Surg. 1998 Apr;133(4):442-7. doi: 10.1001/archsurg.133.4.442.
6
How detrimental is reexploration for bleeding after cardiac surgery?心脏手术后再次探查出血的危害有多大?
J Thorac Cardiovasc Surg. 2017 Sep;154(3):927-935. doi: 10.1016/j.jtcvs.2016.04.097. Epub 2017 May 25.
7
Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery.阿司匹林不会增加再次冠状动脉手术中的异体输血。
Anesth Analg. 1996 Dec;83(6):1178-84. doi: 10.1097/00000539-199612000-00008.
8
Surgical reexploration after cardiac operations: why a worse outcome?心脏手术后再次手术探查:为何预后更差?
Ann Thorac Surg. 2008 Nov;86(5):1557-62. doi: 10.1016/j.athoracsur.2008.07.114.
9
The implication of seniority of supervising attending surgeon on the reexploration rate following elective coronary artery bypass grafting.指导主治外科医生资历对选择性冠状动脉旁路移植术后再次探查率的影响。
J Formos Med Assoc. 2019 Jan;118(1 Pt 2):354-361. doi: 10.1016/j.jfma.2018.06.007. Epub 2018 Jun 20.
10
Obesity is associated with increased morbidity after coronary artery bypass graft surgery in patients with renal insufficiency.肥胖与肾功能不全患者冠状动脉旁路移植术后发病率增加有关。
J Thorac Cardiovasc Surg. 2009 Oct;138(4):873-9. doi: 10.1016/j.jtcvs.2009.02.019. Epub 2009 Apr 8.

引用本文的文献

1
Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial.评估一种新型多糖止血系统在手术中的安全性和有效性:一项多中心多专业前瞻性随机对照试验。
Surg Open Sci. 2024 May 3;19:205-211. doi: 10.1016/j.sopen.2024.04.009. eCollection 2024 Jun.
2
Interpretable machine learning-based predictive modeling of patient outcomes following cardiac surgery.基于可解释机器学习的心脏手术后患者预后预测模型
J Thorac Cardiovasc Surg. 2025 Jan;169(1):114-123.e28. doi: 10.1016/j.jtcvs.2023.11.034. Epub 2023 Nov 29.
3
Acute Kidney Injury after Cardiac Surgery: Prediction, Prevention, and Management.
心脏手术后急性肾损伤:预测、预防和管理。
Anesthesiology. 2023 Dec 1;139(6):880-898. doi: 10.1097/ALN.0000000000004734.
4
Early Re-Exploration versus Conservative Management for Postoperative Bleeding in Stable Patients after Coronary Artery Bypass Grafting: A Propensity Matched Study.冠状动脉搭桥术后稳定患者术后出血的早期再次探查与保守治疗:一项倾向匹配研究
J Clin Med. 2023 May 7;12(9):3327. doi: 10.3390/jcm12093327.
5
Tranexamic acid is associated with improved hemostasis in elderly patients undergoing coronary-artery surgeries in a retrospective cohort study.在一项回顾性队列研究中,氨甲环酸与接受冠状动脉手术的老年患者止血效果改善相关。
Front Surg. 2023 Feb 21;10:1117974. doi: 10.3389/fsurg.2023.1117974. eCollection 2023.
6
Coagulation Tests and Bleeding Classification After Cardiopulmonary Bypass: A Prospective Study.体外循环后凝血试验和出血分类:一项前瞻性研究。
J Cardiothorac Vasc Anesth. 2023 Jun;37(6):933-941. doi: 10.1053/j.jvca.2023.01.038. Epub 2023 Feb 6.
7
Bayesian networks identify determinants of outcomes following cardiac surgery in a UK population.贝叶斯网络确定了英国人群心脏手术后结局的决定因素。
BMC Cardiovasc Disord. 2023 Feb 6;23(1):70. doi: 10.1186/s12872-023-03100-6.
8
Development and validation of a model for surveillance of postoperative bleeding complications using structured electronic health records data.利用结构化电子健康记录数据开发和验证术后出血并发症监测模型。
Surgery. 2022 Dec;172(6):1728-1732. doi: 10.1016/j.surg.2022.08.021. Epub 2022 Sep 20.
9
Five-minute test to prevent postcardiotomy reexploration.预防心脏手术后再次开胸探查的五分钟测试。
JTCVS Tech. 2022 Jan 19;12:121-129. doi: 10.1016/j.xjtc.2021.08.049. eCollection 2022 Apr.
10
A Randomized Pilot Trial Assessing the Role of Human Fibrinogen Concentrate in Decreasing Cryoprecipitate Use and Blood Loss in Infants Undergoing Cardiopulmonary Bypass.一项评估人纤维蛋白原浓缩物在减少体外循环婴儿使用冷沉淀和失血中的作用的随机试点试验。
Pediatr Cardiol. 2022 Oct;43(7):1444-1454. doi: 10.1007/s00246-022-02866-4. Epub 2022 Mar 19.